Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
about
Biological response modifiers in cancerFacilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents.Solution structure of the major G-quadruplex formed in the human VEGF promoter in K+: insights into loop interactions of the parallel G-quadruplexesOncogenomics and the development of new cancer therapiesMechanisms of action of therapeutic antibodies for cancerMolecular imaging agents: impact on diagnosis and therapeutics in oncologyHigh-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafishThe disruption of murine tumor neovasculature by low-intensity ultrasound-comparison between 1- and 3-MHz sonication frequenciesThe antivascular action of physiotherapy ultrasound on a murine tumor: role of a microbubble contrast agent.The antivascular action of physiotherapy ultrasound on murine tumors.Post-treatment imaging changes in primary brain tumors.Rapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantation.Dual VEGF/VEGFR inhibition in advanced solid malignancies: clinical effects and pharmacodynamic biomarkersIn vitro footprinting of promoter regions within supercoiled plasmid DNA.Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2The contribution of a 2-amino group on receptor tyrosine kinase inhibition and antiangiogenic activity in 4-anilinosubstituted pyrrolo[2,3-d]pyrimidinesThe proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex-interactive agents.Radiation necrosis following treatment of high grade glioma--a review of the literature and current understanding.Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity.Antibodies and Tyrosine Kinase Inhibitors in Breast Cancer Therapies.Acidity generated by the tumor microenvironment drives local invasionThe relationship of vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer.Evidence of the formation of G-quadruplex structures in the promoter region of the human vascular endothelial growth factor geneTargeted therapies in the management of renal cell carcinoma: role of bevacizumabImaging cycling tumor hypoxia.Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways.Rapid in vitro derivation of endothelium directly from human cancer cells.N-acetyl-cysteine promotes angiostatin production and vascular collapse in an orthotopic model of breast cancer.Molecular mechanisms of angiogenesis in non-small cell lung cancer, and therapeutics targeting related molecules.Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.Tumor hypoxia: a target for selective cancer therapy.Cabozantinib, a Novel c-Met Inhibitor, Inhibits Colorectal Cancer Development in a Xenograft Model.Tumor treating field therapy in combination with bevacizumab for the treatment of recurrent glioblastomaEffects of androgen suppression and radiation on prostate cancer suggest a role for angiogenesis blockade.Inhibition of angiogenesis in cancer patients.Delivery of antiangiogenic agents for cancer gene therapy.Scutellaria barbata D. Don inhibits tumor angiogenesis via suppression of Hedgehog pathway in a mouse model of colorectal cancer.Molecular ultrasound imaging using a targeted contrast agent for assessing early tumor response to antiangiogenic therapyMolecule action mechanisms of NM-3 on human gastric cancer SGC-7901 cells in vivo or in vitro
P2860
Q24685049-9DAE2718-F6E5-4B1F-A314-6DF07EC3BA65Q24816211-F99A0A94-5A70-47D5-9196-FAFF17E8F809Q27679870-B2D9EA63-05CD-4749-B7B5-04CD5B9D672EQ28263634-131979CA-1D96-4A34-AD41-890167364494Q28385366-0926ED23-A657-4D4C-8DE1-BC4E211DACF5Q30433423-F9AE2120-9CC9-4C02-BC43-E049927C830EQ30480643-C7AFCEC3-1204-4B76-85F8-3FA7ABF69F53Q30487042-08130275-5C36-417C-949F-F0CC365AE3AFQ30492402-BAEC2CC8-41ED-4988-ABFA-CC8FA98B499AQ30494087-01A542BB-1938-4EAC-B01A-DB211BE7A257Q30835236-4825A8DF-2EE3-438F-81EE-1A926B64AD91Q30986337-41AD386C-1589-4E7B-9673-0F3B0D7F691FQ33415397-0183561A-2841-491E-8FD7-29A43B30FA17Q33594169-E2DE31D5-5530-407E-AB8A-2E889928E081Q33733451-E7F3EE30-E892-492D-9866-66E720029DE6Q33835807-EA2B54EA-57B1-4764-A92A-45DB183C4A38Q34011118-A198C330-5BC4-4BCB-95E1-749864C48851Q34087196-08ECFD0E-C2FE-43F4-9E61-6B8238FA8765Q34129496-3E0E8C08-1B86-4CA2-9D4E-9A6F065508D7Q34140167-458E6811-710A-484B-BA60-4B8D42535304Q34320819-ACD73563-19F6-4289-886F-0015E4A5EAB3Q34572068-69373DA7-7231-4804-85AA-7743E38AA01DQ34609291-A25C41E0-DDAC-43A0-9AD2-19CB7772CD7EQ34611205-80B17342-F302-4509-8071-8E5710A96B36Q34686519-23A6EAB6-3E66-4537-A13A-DA0D847FB06DQ34787415-B3BE987C-4A5E-4BA4-8D91-0B61179EFCBDQ35018915-E7627AD9-EEC7-4AFA-87ED-C9464A598F7EQ35098081-97DE19CD-3EA8-4FEC-A68C-3C0060EA08B2Q35161738-5F643C61-A4D0-4550-B3E6-81242101E258Q35182294-51B5278C-E213-4AD8-AFB0-E8016D93C1B5Q35581064-9356B6A4-992F-4FEA-8CC5-BCBB8967B925Q35602696-BD915F52-A8D9-4EF3-9C3A-E6D0043F53AEQ35954738-AF0CFAD0-2ABE-4370-9945-9FCAD189EDE8Q35970661-B8238629-677B-406C-97BF-1EEE443567FCQ36005858-3B84A31B-E936-470C-81A0-33EB9B51CAD3Q36150646-4403C6FB-1479-46B8-A393-C937EE9A4900Q36200143-A501E1F6-1D28-4391-9994-1B66FAC132EFQ36202240-3F94004E-4896-482F-9235-E5AB179A9D8EQ36297117-659E30CB-E51F-4EF6-9DBE-9074D5E8DADDQ36308777-4B96F6D5-628A-4BF4-A128-4F40282E05B3
P2860
Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
@ast
Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
@en
type
label
Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
@ast
Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
@en
prefLabel
Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
@ast
Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
@en
P356
P1433
P1476
Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
@en
P2093
Rakesh K Jain
P356
10.1053/SONC.2002.37265
P433
6 Suppl 16
P577
2002-12-01T00:00:00Z